{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:11:18Z","timestamp":1793747478646,"version":"4.6.1"},"reference-count":76,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["20-15-00364"],"award-info":[{"award-number":["20-15-00364"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Atherosclerosis has complex pathogenesis, which involves at least three serious aspects: inflammation, lipid metabolism alterations, and endothelial injury. There are no effective treatment options, as well as preventive measures for atherosclerosis. However, this disease has various severe complications, the most severe of which is cardiovascular disease (CVD). It is important to note, that CVD is among the leading causes of death worldwide. The renin\u2013angiotensin\u2013aldosterone system (RAAS) is an important part of inflammatory response regulation. This system contributes to the recruitment of inflammatory cells to the injured site and stimulates the production of various cytokines, such as IL-6, TNF-a, and COX-2. There is also an association between RAAS and oxidative stress, which is also an important player in atherogenesis. Angiotensin-II induces plaque formation at early stages, and this is one of the most crucial impacts on atherogenesis from the RAAS. Importantly, while stimulating the production of ROS, Angiotensin-II at the same time decreases the generation of NO. The endothelium is known as a major contributor to vascular function. Oxidative stress is the main trigger of endothelial dysfunction, and, once again, links RAAS to the pathogenesis of atherosclerosis. All these implications of RAAS in atherogenesis lead to an explicable conclusion that elements of RAAS can be promising targets for atherosclerosis treatment. In this review, we also summarize the data on treatment approaches involving cytokine targeting in CVD, which can contribute to a better understanding of atherogenesis and even its prevention.<\/jats:p>","DOI":"10.3390\/ijms22136702","type":"journal-article","created":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T22:10:59Z","timestamp":1624399859000},"page":"6702","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":128,"title":["Renin-Angiotensin System in Pathogenesis of Atherosclerosis and Treatment of CVD"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1516-1320","authenticated-orcid":false,"given":"Anastasia V.","family":"Poznyak","sequence":"first","affiliation":[{"name":"Institute for Atherosclerosis Research, Skolkovo Innovative Center, 121609 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dwaipayan","family":"Bharadwaj","sequence":"additional","affiliation":[{"name":"Academy of Scientific and Innovative Research, CSIR-Institute of Genomics and Integrative Biology Campus, New Delhi 110067, India"},{"name":"Systems Genomics Laboratory, School of Biotechnology, Jawaharlal Nehru University, New Delhi 110067, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gauri","family":"Prasad","sequence":"additional","affiliation":[{"name":"Systems Genomics Laboratory, School of Biotechnology, Jawaharlal Nehru University, New Delhi 110067, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey V.","family":"Grechko","sequence":"additional","affiliation":[{"name":"Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, 14-3 Solyanka Street, 109240 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8610-4593","authenticated-orcid":false,"given":"Margarita A.","family":"Sazonova","sequence":"additional","affiliation":[{"name":"Laboratory of Angiopathology, Institute of General Pathology and Pathophysiology, 125315 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3318-4681","authenticated-orcid":false,"given":"Alexander N.","family":"Orekhov","sequence":"additional","affiliation":[{"name":"Institute for Atherosclerosis Research, Skolkovo Innovative Center, 121609 Moscow, Russia"},{"name":"Laboratory of Angiopathology, Institute of General Pathology and Pathophysiology, 125315 Moscow, Russia"},{"name":"Institute of Human Morphology, 3 Tsyurupa Street, 117418 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,6,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"613780","DOI":"10.3389\/fphar.2020.613780","article-title":"Overview of OxLDL and its impact on cardiovascular health: Focus on atherosclerosis","volume":"11","author":"Poznyak","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Wu, M.Y., Li, C.J., Hou, M.F., and Chu, P.Y. (2017). new insights into the role of inflammation in the pathogenesis of atherosclerosis. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18102034"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Kovanen, P.T. (2019). Mast cells as potential accelerators of human atherosclerosis\u2014From early to late lesions. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20184479"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Poznyak, A.V., Wu, W.K., Melnichenko, A.A., Wetzker, R., Sukhorukov, V., Markin, A.M., Khotina, V.A., and Orekhov, A.N. (2020). Signaling pathways and key genes involved in regulation of foam cell formation in atherosclerosis. Cells, 9.","DOI":"10.3390\/cells9030584"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11883-017-0678-6","article-title":"Oxidative stress in atherosclerosis","volume":"19","author":"Kattoor","year":"2017","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/clinchem\/hvaa275","article-title":"Inflammation in atherosclerosis\u2014No longer a theory","volume":"67","author":"Libby","year":"2021","journal-title":"Clin. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"689360","DOI":"10.1155\/2014\/689360","article-title":"The renin-angiotensin-aldosterone system in vascular inflammation and remodeling","volume":"2014","author":"Pacurari","year":"2014","journal-title":"Int. J. Inflamm."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1152\/physrev.00038.2017","article-title":"Angiotensin II signal transduction: An update on mechanisms of physiology and pathophysiology","volume":"98","author":"Forrester","year":"2018","journal-title":"Physiol. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Kolakovic, A., Zivkovic, M., and Stankovic, A. (2017). Involvement of the renin-angiotensin system in atherosclerosis, renin-angiotensin system\u2014Past, present and future. IntechOpen, Available online: https:\/\/www.intechopen.com\/books\/renin-angiotensin-system-past-present-and-future\/involvement-of-the-renin-angiotensin-system-in-atherosclerosis.","DOI":"10.5772\/67137"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1515\/cclm-2020-0601","article-title":"The emerging role of cell senescence in atherosclerosis","volume":"59","author":"Wu","year":"2020","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1161\/01.CIR.0000061916.95736.E5","article-title":"C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle","volume":"107","author":"Wang","year":"2003","journal-title":"Circulation"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Fiordelisi, A., Iaccarino, G., Morisco, C., Coscioni, E., and Sorriento, D. (2019). NFkappaB is a key player in the crosstalk between inflammation and cardiovascular diseases. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20071599"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11892-009-0081-y","article-title":"Pleiotropic effects of inhibitors of the RAAS in the diabetic population: Above and beyond blood pressure lowering","volume":"10","author":"Ismail","year":"2010","journal-title":"Curr. Diabetes Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1161\/01.CIR.0000140265.21608.8E","article-title":"Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation","volume":"110","author":"Fliser","year":"2004","journal-title":"Circulation"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1097\/HJH.0b013e3282ef79f7","article-title":"Olmesartan and pravastatin additively reduce development of atherosclerosis in APOE*3Leiden transgenic mice","volume":"25","author":"Kleemann","year":"2007","journal-title":"J. Hypertens."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2152\/jmi.57.12","article-title":"Crucial role of renin-angiotensin system in the pathogenesis of atherosclerosis","volume":"57","author":"Sata","year":"2010","journal-title":"J. Med. Investig."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e000018","DOI":"10.1161\/JAHA.112.000018","article-title":"Aldosterone increases early atherosclerosis and promotes plaque inflammation through a placental growth factor-dependent mechanism","volume":"2","author":"McGraw","year":"2013","journal-title":"J. Am. Heart Assoc."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1177\/1470320312467558","article-title":"Mineralocorticoid receptor blockade inhibits accelerated atherosclerosis induced by a low sodium diet in apolipoprotein E-deficient mice","volume":"15","author":"Gantman","year":"2014","journal-title":"J. Renin. Angiotensin Aldosterone Syst."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"108453","DOI":"10.1016\/j.abb.2020.108453","article-title":"Dietary nitrate attenuated endothelial dysfunction and atherosclerosis in apolipoprotein E knockout mice fed a high-fat diet: A critical role for NADPH oxidase","volume":"689","author":"Peng","year":"2020","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2174\/138161212799436467","article-title":"Role of the renin-angiotensin-aldosterone system in the pathogenesis of atherosclerosis","volume":"18","author":"Durante","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Poznyak, A.V., Grechko, A.V., Orekhova, V.A., Khotina, V., Ivanova, E.A., and Orekhov, A.N. (2020). NADPH oxidases and their role in atherosclerosis. Biomedicines, 8.","DOI":"10.3390\/biomedicines8070206"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s11906-014-0431-2","article-title":"Angiotensin II and vascular injury","volume":"16","author":"Montezano","year":"2014","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_23","first-page":"405","article-title":"NADPH oxidase-dependent formation of reactive oxygen species contributes to angiotensin II-induced epithelial-mesenchymal transition in rat peritoneal mesothelial cells","volume":"28","author":"Chang","year":"2011","journal-title":"Int. J. Mol. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/bs.ircmb.2017.07.007","article-title":"NF-\u03baB and the transcriptional control of inflammation","volume":"335","author":"Mitchell","year":"2018","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1007\/s00018-020-03453-7","article-title":"Infection and atherosclerosis: TLR-dependent pathways","volume":"77","author":"Li","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.exer.2007.06.013","article-title":"Pro-inflammatory cytokines increase reactive oxygen species through mitochondria and NADPH oxidase in cultured RPE cells","volume":"85","author":"Yang","year":"2007","journal-title":"Exp. Eye Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40292-019-00356-y","article-title":"From endothelium to lipids, through microRNAs and PCSK9: A fascinating travel across atherosclerosis","volume":"27","author":"Santilli","year":"2020","journal-title":"High Blood Press. Cardiovasc. Prev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.3346\/jkms.2015.30.9.1213","article-title":"Endothelial dysfunction: Clinical implications in cardiovascular disease and therapeutic approaches","volume":"30","author":"Park","year":"2015","journal-title":"J. Korean Med. Sci."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Meza, C.A., Favor, J.D.L., Kim, D.H., and Hickner, R.C. (2019). Endothelial dysfunction: Is there a hyperglycemia-induced imbalance of NOX and NOS?. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20153775"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jacc.2017.05.035","article-title":"Impact of oxidative stress on the heart and vasculature: Part 2 of a 3-part series","volume":"70","author":"Camici","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/CIRCRESAHA.115.306361","article-title":"Vascular smooth muscle cells in atherosclerosis","volume":"118","author":"Bennett","year":"2016","journal-title":"Circ. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"6751","DOI":"10.21873\/anticanres.14698","article-title":"Nitric oxide inhibits NF-\u03baB-mediated survival signaling: Possible role in overcoming TRAIL resistance","volume":"40","author":"Bauer","year":"2020","journal-title":"Anticancer Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s10787-007-0013-x","article-title":"Role of nitric oxide in inflammatory diseases","volume":"15","author":"Sharma","year":"2007","journal-title":"Inflammopharmacology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3389\/fimmu.2018.00586","article-title":"Age and age-related diseases: Role of inflammation triggers and cytokines","volume":"9","author":"Rea","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Takeda, Y., Matoba, K., Sekiguchi, K., Nagai, Y., Yokota, T., Utsunomiya, K., and Nishimura, R. (2020). Endothelial dysfunction in diabetes. Biomedicines, 8.","DOI":"10.3390\/biomedicines8070182"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Mu\u00f1oz-Durango, N., Fuentes, C.A., Castillo, A.E., Gonz\u00e1lez-G\u00f3mez, L.M., Vecchiola, A., Fardella, C.E., and Kalergis, A.M. (2016). Role of the renin-angiotensin-aldosterone system beyond blood pressure regulation: Molecular and cellular mechanisms involved in end-organ damage during arterial hypertension. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17070797"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.3389\/fimmu.2019.02046","article-title":"Plasminflammation\u2013An emerging pathway to bradykinin production","volume":"10","author":"Maas","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/XCE.0000000000000172","article-title":"Atherosclerosis: Integration of its pathogenesis as a self-perpetuating propagating inflammation: A review","volume":"8","author":"Poston","year":"2019","journal-title":"Cardiovasc. Endocrinol. Metab."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Nehme, A., Zouein, F.A., Zayeri, Z.D., and Zibara, K. (2019). An update on the tissue renin angiotensin system and its role in physiology and pathology. J. Cardiovasc. Dev. Dis., 6.","DOI":"10.3390\/jcdd6020014"},{"key":"ref_40","unstructured":"Morato, M., Reina-Couto, M., Pinho, D., Albino-Teixeira, A., and Sousa, T. (2020). Regulation of the renin-angiotensin-aldosterone system by reactive oxygen species, renin-angiotensin system\u2014Past, present and future. IntechOpen, Available online: https:\/\/www.intechopen.com\/books\/renin-angiotensin-system-past-present-and-future\/regulation-of-the-renin-angiotensin-aldosterone-system-by-reactive-oxygen-species."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Paul, A.S., Corbett, C.B., Okune, R., and Autieri, M.V. (2020). Angiotensin II, hypercholesterolemia, and vascular smooth muscle cells: A perfect trio for vascular pathology. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21124525"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1161\/01.HYP.35.1.353","article-title":"Angiotensin-converting enzyme expression in human carotid artery atherosclerosis","volume":"35","author":"Fukuhara","year":"2000","journal-title":"Hypertension"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.phrs.2017.05.020","article-title":"Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease","volume":"125","author":"Ferrario","year":"2017","journal-title":"Pharmacol. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nrcardio.2014.59","article-title":"Angiotensin-converting enzyme 2 and angiotensin 1\u20137: Novel therapeutic targets","volume":"11","author":"Jiang","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1161\/ATVBAHA.113.301320","article-title":"Angiotensin-(1\u20137) dose-dependently inhibits atherosclerotic lesion formation and enhances plaque stability by targeting vascular cells","volume":"33","author":"Yang","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41569-019-0244-8","article-title":"Counter-regulatory renin-angiotensin system in cardiovascular disease","volume":"17","author":"Ocaranza","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1161\/ATVBAHA.109.200493","article-title":"Improved lipid and glucose metabolism in transgenic rats with increased circulating angiotensin-(1\u20137)","volume":"30","author":"Santos","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/1440-1681.13251","article-title":"The potential actions of angiotensin-converting enzyme II (ACE2) activator diminazene aceturate (DIZE) in various diseases","volume":"47","author":"Qaradakhi","year":"2020","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2174\/0929866522666150209125401","article-title":"Angiotensin converting enzyme 2 activator (DIZE) modulates metabolic profiles in mice, decreasing lipogenesis","volume":"22","author":"Macedo","year":"2015","journal-title":"Protein Pept. Lett."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2174\/0929866522666151013130550","article-title":"Anti-hypertensive effects of diminazene aceturate: An angiotensin\u2014Converting enzyme 2 activator in rats","volume":"23","author":"Maria","year":"2016","journal-title":"Protein Pept. Lett."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3389\/fphys.2020.01067","article-title":"Role of renin-angiotensin system components in atherosclerosis: Focus on Ang-II, ACE2, and Ang-1\u20137","volume":"11","author":"Silva","year":"2020","journal-title":"Front. Physiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"209","DOI":"10.4331\/wjbc.v6.i3.209","article-title":"Inflammation, oxidative stress and renin angiotensin system in atherosclerosis","volume":"6","author":"Husain","year":"2015","journal-title":"World J. Biol. Chem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1161\/CIRCRESAHA.118.313568","article-title":"Medical therapy for heart failure caused by ischemic heart disease","volume":"124","author":"Elgendy","year":"2019","journal-title":"Circ. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.atherosclerosis.2015.02.055","article-title":"Comparison of angiotensin-(1\u20137), losartan and their combination on atherosclerotic plaque formation in apolipoprotein E knockout mice","volume":"240","author":"Yang","year":"2015","journal-title":"Atherosclerosis"},{"key":"ref_55","first-page":"77","article-title":"Angiotensin-(1\u20137) receptor Mas agonist ameliorates progress of atherosclerosis in apoE-knockout mice","volume":"63","author":"Jawien","year":"2012","journal-title":"J. Physiol. Pharmacol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"BR389","DOI":"10.12659\/MSM.883478","article-title":"The effect of AVE 0991, nebivolol and doxycycline on inflammatory mediators in an apoE-knockout mouse model of atherosclerosis","volume":"18","author":"Jawien","year":"2012","journal-title":"Med. Sci. Monit."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1042\/CS20130436","article-title":"Angiotensin-(1\u20137) and angiotensin-(1\u20139): Function in cardiac and vascular remodelling","volume":"126","author":"McKinney","year":"2014","journal-title":"Clin. Sci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/ATVBAHA.110.204453","article-title":"Vasoprotective and atheroprotective effects of angiotensin (1\u20137) in apolipoprotein E-deficient mice","volume":"30","author":"Tesanovic","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"11903","DOI":"10.1038\/s41598-017-12074-3","article-title":"Ang-(1\u20137) is an endogenous \u03b2-arrestin-biased agonist of the AT1 receptor with protective action in cardiac hypertrophy","volume":"7","author":"Teixeira","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_60","first-page":"287","article-title":"Monocytic angiotensin-converting enzyme 2 relates to atherosclerosis in patients with chronic kidney disease","volume":"32","author":"Trojanowicz","year":"2017","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1177\/1470320314542829","article-title":"ACE2 activity was increased in atherosclerotic plaque by losartan: Possible relation to anti-atherosclerosis","volume":"16","author":"Zhang","year":"2015","journal-title":"J. Renin. Angiotensin Aldosterone Syst."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1164\/rccm.201205-0880OC","article-title":"Diminazene attenuates pulmonary hypertension and improves angiogenic progenitor cell functions in experimental models","volume":"187","author":"Shenoy","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.vph.2015.08.014","article-title":"Diminazene enhances stability of atherosclerotic plaques in ApoE-deficient mice","volume":"74","author":"Montecucco","year":"2015","journal-title":"Vascul. Pharmacol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"107680","DOI":"10.1016\/j.exer.2019.05.020","article-title":"The renin-angiotensin-aldosterone system and its therapeutic targets","volume":"186","author":"Danser","year":"2019","journal-title":"Exp. Eye Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10557-014-6562-5","article-title":"Oxidative stress and early atherosclerosis: Novel antioxidant treatment","volume":"29","author":"Tousoulis","year":"2015","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ahj.2015.12.021","article-title":"Effect of angiotensin II type I receptor blockade with valsartan on carotid artery atherosclerosis: A double blind randomized clinical trial comparing valsartan and placebo (EFFERVESCENT)","volume":"174","author":"Ramadan","year":"2016","journal-title":"Am. Heart. J."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Zwadlo, C., and Bauersachs, J. (2019). Mineralocorticoid receptor antagonists in the treatment of coronary artery disease, myocardial infarction and heart failure, aldosterone-mineralocorticoid receptor\u2014Cell biology to translational medicine. IntechOpen, Available online: https:\/\/www.intechopen.com\/books\/aldosterone-mineralocorticoid-receptor-cell-biology-to-translational-medicine\/mineralocorticoid-receptor-antagonists-in-the-treatment-of-coronary-artery-disease-myocardial-infar.","DOI":"10.5772\/intechopen.87224"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1253\/circj.CJ-17-0323","article-title":"Double-blind, randomized, placebo-controlled trial evaluating the efficacy and safety of eplerenone in Japanese patients with chronic heart failure (J-EMPHASIS-HF)","volume":"82","author":"Tsutsui","year":"2017","journal-title":"Circ. J."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1161\/CIRCULATIONAHA.108.778811","article-title":"Serum potassium and clinical outcomes in the eplerenone post-acute myocardial infarction heart failure efficacy and survival study (EPHESUS)","volume":"118","author":"Pitt","year":"2008","journal-title":"Circulation"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.jacc.2016.02.033","article-title":"ALBATROSS Investigators. Early aldosterone blockade in acute myocardial infarction: The ALBATROSS randomized clinical trial","volume":"67","author":"Beygui","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ahj.2011.06.015","article-title":"Measuring and targeting aldosterone and renin in atherosclerosis-a review of clinical data","volume":"162","author":"Hillaert","year":"2011","journal-title":"Am. Heart. J."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"115466","DOI":"10.1016\/j.bmc.2020.115466","article-title":"Decades-old renin inhibitors are still struggling to find a niche in antihypertensive therapy. A fleeting look at the old and the promising new molecules","volume":"28","author":"Ramya","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"ref_73","first-page":"CD007066","article-title":"Blood pressure lowering efficacy of renin inhibitors for primary hypertension","volume":"4","author":"Musini","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_74","first-page":"586","article-title":"Aliskiren inhibits neointimal matrix metalloproteinases in experimental atherosclerosis","volume":"32","author":"Wu","year":"2016","journal-title":"Acta Cardiol. Sin."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"719","DOI":"10.4330\/wjc.v7.i11.719","article-title":"Vascular endothelial dysfunction and pharmacological treatment","volume":"7","author":"Su","year":"2015","journal-title":"World J. Cardiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"e004879","DOI":"10.1161\/JAHA.112.004879","article-title":"Aliskiren effect on plaque progression in established atherosclerosis using high resolution 3D MRI (ALPINE): A double-blind placebo-controlled trial","volume":"2","author":"Mihai","year":"2013","journal-title":"J. Am. Heart Assoc."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/13\/6702\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:21:31Z","timestamp":1760163691000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/13\/6702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,22]]},"references-count":76,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2021,7]]}},"alternative-id":["ijms22136702"],"URL":"https:\/\/doi.org\/10.3390\/ijms22136702","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,22]]}}}